Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 5.30
- Piotroski Score 6.00
- Grade Overweight
- Symbol (MASI)
- Company Masimo Corporation
- Price $172.48
- Changes Percentage (0.46%)
- Change $0.79
- Day Low $170.11
- Day High $173.17
- Year High $178.28
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
- Last Earnings 11/01/2012
- Ex-Dividend for 5/16 Dividend 11/23/2012
- Dividend Payable 12/11/2012
- Today N/A
- Next Earnings (Estimated) 02/24/2025
- Fiscal Year End N/A
- Average Stock Price Target $167.50
- High Stock Price Target $170.00
- Low Stock Price Target $136.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.47
- Trailing P/E Ratio 85.35
- Forward P/E Ratio 85.35
- P/E Growth 85.35
- Net Income $81.50 M
Income Statement
Quarterly
Annual
Latest News of MASI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Bunting, Letang and Tomasino score on the power play, lifting the Penguins over the Flames 6-2
The Pittsburgh Penguins defeated the Calgary Flames 6-2 with strong performances from Bunting, Letang, and Nedeljkovic. Calgary struggled with power-play goals, while Pittsburgh won three straight gam...
By CBS News | 2 days ago -
Kyle Dubas' bet on Philip Tomasino pays off, Tristan Jarry takes big step for Penguins: 3 takeaways
Critics label Kyle Dubas as a failed GM, but his strategic moves are showing promise. His acquisition of Philip Tomasino could benefit the Penguins, especially Malkin. Tristan Jarry's performance in B...
By The New York Times | 3 days ago -
Hedge Fund RTW Probed by SEC Over Role in Masimo Proxy Fight
RTW Investments, a $6.5 billion hedge fund, is under SEC investigation for its role in a proxy fight at Masimo Corp. The firm denies any wrongdoing and is cooperating with authorities. Masimo had sued...
By Yahoo! Finance | 6 days ago
